Lantheus MI Radipharmaceuticals Inc.

FDA Regulatory Profile

Lantheus MI Radipharmaceuticals Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0942-2017, Class III) was initiated on May 18, 2017.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0942-2017Class IIIFludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, MaMay 18, 2017